Bruce L. Levine Center for Cellular Immunotherapies, Perelman School of Medicine University of Pennsylvania Biography Publications Institution JoVE Articles Bruce L. Levine has not added a biography. If you are Bruce L. Levine and would like to personalize this page please email our Author Liaison for assistance. Publications B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Re-expansion in a Patient with Myeloma Following Salvage Programmed Cell Death Protein 1 Inhibitor-based Combination Therapy British Journal of Haematology. Mar, 2021 | Pubmed ID: 33713436 CCR5-edited CD4 T Cells Augment HIV-specific Immunity to Enable Post Rebound Control of HIV Replication The Journal of Clinical Investigation. Feb, 2021 | Pubmed ID: 33571163 Author Correction: Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy of Chronic Lymphocytic Leukemia Nature Medicine. Feb, 2021 | Pubmed ID: 33547459 The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products? Stem Cells and Development. 02, 2021 | Pubmed ID: 33307968 Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals Molecular Therapy : the Journal of the American Society of Gene Therapy. 02, 2021 | Pubmed ID: 33186691 Diagnostic Biomarkers to Differentiate Sepsis from Cytokine Release Syndrome in Critically Ill Children Blood Advances. 10, 2020 | Pubmed ID: 33095872 Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer Molecular Therapy : the Journal of the American Society of Gene Therapy. 11, 2020 | Pubmed ID: 32730744 Emerging Trends in COVID-19 Treatment: Learning from Inflammatory Conditions Associated with Cellular Therapies Cytotherapy. 09, 2020 | Pubmed ID: 32565132 International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy Statement on Extracellular Vesicles from Mesenchymal Stromal Cells and Other Cells: Considerations for Potential Therapeutic Agents to Suppress Coronavirus Disease-19 Cytotherapy. 09, 2020 | Pubmed ID: 32425691 Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 09, 2020 | Pubmed ID: 32298202 Accelerating the Development of Innovative Cellular Therapy Products for the Treatment of Cancer Cytotherapy. 05, 2020 | Pubmed ID: 32199724 CRISPR-engineered T Cells in Patients with Refractory Cancer Science (New York, N.Y.). 02, 2020 | Pubmed ID: 32029687 The Long Road to the First FDA-approved Gene Therapy: Chimeric Antigen Receptor T Cells Targeting CD19 Cytotherapy. 02, 2020 | Pubmed ID: 32014447 CAR T-cell Product Performance in Haematological Malignancies Before and After Marketing Authorisation The Lancet. Oncology. 02, 2020 | Pubmed ID: 32007196 CD19-targeting CAR T Cell Immunotherapy Outcomes Correlate with Genomic Modification by Vector Integration The Journal of Clinical Investigation. 02, 2020 | Pubmed ID: 31845905 Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 02, 2020 | Pubmed ID: 31815579 Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies Methods in Molecular Biology (Clifton, N.J.). 2020 | Pubmed ID: 31707678 T-cell Phenotypes Associated with Effective CAR T-cell Therapy in Postinduction Vs Relapsed Multiple Myeloma Blood Advances. 10, 2019 | Pubmed ID: 31575532 CAR T Cell Viability Release Testing and Clinical Outcomes: is There a Lower Limit? Blood. 11, 2019 | Pubmed ID: 31554634 A Multiscale Simulation Framework for the Manufacturing Facility and Supply Chain of Autologous Cell Therapies Cytotherapy. 10, 2019 | Pubmed ID: 31445816 Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers Molecular Therapy : the Journal of the American Society of Gene Therapy. 11, 2019 | Pubmed ID: 31420241 B Cell Maturation Antigen-specific CAR T Cells Are Clinically Active in Multiple Myeloma The Journal of Clinical Investigation. 03, 2019 | Pubmed ID: 30896447 Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells CPT: Pharmacometrics & Systems Pharmacology. 05, 2019 | Pubmed ID: 30848084 Chimeric Antigen Receptor-T Cell Therapy Manufacturing: Modelling the Effect of Offshore Production on Aggregate Cost of Goods Cytotherapy. 02, 2019 | Pubmed ID: 30770285 Powered and Controlled T-cell Production Nature Biomedical Engineering. 03, 2018 | Pubmed ID: 31015722 CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success Frontiers in Immunology. 2018 | Pubmed ID: 30559740 Induction of Resistance to Chimeric Antigen Receptor T Cell Therapy by Transduction of a Single Leukemic B Cell Nature Medicine. 10, 2018 | Pubmed ID: 30275568 Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 12, 2018 | Pubmed ID: 30190371 Reducing Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells Cancer Immunology Research. 09, 2018 | Pubmed ID: 30030295 Nonviral RNA Chimeric Antigen Receptor-modified T Cells in Patients with Hodgkin Lymphoma Blood. 09, 2018 | Pubmed ID: 29925499 Disruption of TET2 Promotes the Therapeutic Efficacy of CD19-targeted T Cells Nature. 06, 2018 | Pubmed ID: 29849141 Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy of Chronic Lymphocytic Leukemia Nature Medicine. 05, 2018 | Pubmed ID: 29713085 Anti-CD19 CAR T Cells with High-dose Melphalan and Autologous Stem Cell Transplantation for Refractory Multiple Myeloma JCI Insight. 04, 2018 | Pubmed ID: 29669947 Personalized Cancer Vaccine Effectively Mobilizes Antitumor T Cell Immunity in Ovarian Cancer Science Translational Medicine. 04, 2018 | Pubmed ID: 29643231 Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial Gastroenterology. 07, 2018 | Pubmed ID: 29567081 Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia The New England Journal of Medicine. 02, 2018 | Pubmed ID: 29385370 Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients Molecular Therapy : the Journal of the American Society of Gene Therapy. 01, 2018 | Pubmed ID: 29203150 Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas The New England Journal of Medicine. 12, 2017 | Pubmed ID: 29226764 Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer Cancer Immunology Research. 12, 2017 | Pubmed ID: 29109077 Exploring Synthetic Immunity: From Boutique to Global Human Vaccines & Immunotherapeutics. 10, 2017 | Pubmed ID: 28945504 Cellular Kinetics of CTL019 in Relapsed/refractory B-cell Acute Lymphoblastic Leukemia and Chronic Lymphocytic Leukemia Blood. 11, 2017 | Pubmed ID: 28935694 Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy Current Hematologic Malignancy Reports. 08, 2017 | Pubmed ID: 28762038 A Single Dose of Peripherally Infused EGFRvIII-directed CAR T Cells Mediates Antigen Loss and Induces Adaptive Resistance in Patients with Recurrent Glioblastoma Science Translational Medicine. 07, 2017 | Pubmed ID: 28724573 Monocyte Lineage-derived IL-6 Does Not Affect Chimeric Antigen Receptor T-cell Function Cytotherapy. 07, 2017 | Pubmed ID: 28506444 Global Manufacturing of CAR T Cell Therapy Molecular Therapy. Methods & Clinical Development. Mar, 2017 | Pubmed ID: 28344995 Showcasing Clinical Development and Production of Cellular Therapies Molecular Therapy : the Journal of the American Society of Gene Therapy. 04, 2017 | Pubmed ID: 28341560 PD-1 Blockade Modulates Chimeric Antigen Receptor (CAR)-modified T Cells: Refueling the CAR Blood. 02, 2017 | Pubmed ID: 28031179 Optimization of CGMP Purification and Expansion of Umbilical Cord Blood-derived T-regulatory Cells in Support of First-in-human Clinical Trials Cytotherapy. 02, 2017 | Pubmed ID: 27887864 Engineered T Cells: the Promise and Challenges of Cancer Immunotherapy Nature Reviews. Cancer. 08, 2016 | Pubmed ID: 27550819 MiR-146b Antagomir-treated Human Tregs Acquire Increased GVHD Inhibitory Potency Blood. 09, 2016 | Pubmed ID: 27485827 Novel Gene and Cellular Therapy Approaches for Treating HIV Discovery Medicine. 04, 2016 | Pubmed ID: 27232514 Identification of Predictive Biomarkers for Cytokine Release Syndrome After Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia Cancer Discovery. 06, 2016 | Pubmed ID: 27076371 Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist The Oncologist. 05, 2016 | Pubmed ID: 27009942 Infusion of CD3/CD28 Costimulated Umbilical Cord Blood T Cells at the Time of Single Umbilical Cord Blood Transplantation May Enhance Engraftment American Journal of Hematology. May, 2016 | Pubmed ID: 26858124 Smart CARS: Optimized Development of a Chimeric Antigen Receptor (CAR) T Cell Targeting Epidermal Growth Factor Receptor Variant III (EGFRvIII) for Glioblastoma Annals of Translational Medicine. Jan, 2016 | Pubmed ID: 26855949 Ibrutinib Enhances Chimeric Antigen Receptor T-cell Engraftment and Efficacy in Leukemia Blood. Mar, 2016 | Pubmed ID: 26813675 Phase I Study of Multi-gene Cell Therapy in Patients with Peripheral Artery Disease Vascular Medicine (London, England). Feb, 2016 | Pubmed ID: 26584888 Umbilical Cord Blood-derived T Regulatory Cells to Prevent GVHD: Kinetics, Toxicity Profile, and Clinical Effect Blood. Feb, 2016 | Pubmed ID: 26563133 T Cell Engineering As Therapy for Cancer and HIV: Our Synthetic Future Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. Oct, 2015 | Pubmed ID: 26416683 Chimeric Antigen Receptor T Cells Against CD19 for Multiple Myeloma The New England Journal of Medicine. Sep, 2015 | Pubmed ID: 26352815 Chimeric Antigen Receptor T Cells Persist and Induce Sustained Remissions in Relapsed Refractory Chronic Lymphocytic Leukemia Science Translational Medicine. Sep, 2015 | Pubmed ID: 26333935 NY-ESO-1-specific TCR-engineered T Cells Mediate Sustained Antigen-specific Antitumor Effects in Myeloma Nature Medicine. Aug, 2015 | Pubmed ID: 26193344 High-Dose Sirolimus and Immune-Selective Pentostatin Plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2015 | Pubmed ID: 26071480 The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2015 | Pubmed ID: 25712684 Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia The New England Journal of Medicine. Oct, 2014 | Pubmed ID: 25317870 Engineered T Cells for Cancer Therapy Cancer Immunology, Immunotherapy : CII. Sep, 2014 | Pubmed ID: 24943274 Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV The New England Journal of Medicine. Mar, 2014 | Pubmed ID: 24597865 Mesothelin-specific Chimeric Antigen Receptor MRNA-engineered T Cells Induce Anti-tumor Activity in Solid Malignancies Cancer Immunology Research. Feb, 2014 | Pubmed ID: 24579088 Combination Immunotherapy After ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-primed and Costimulated Autologous T Cells Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2014 | Pubmed ID: 24520093 Adoptive Immunotherapy for Cancer or Viruses Annual Review of Immunology. 2014 | Pubmed ID: 24423116 T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans Cancer Immunology Research. Jul, 2013 | Pubmed ID: 24777247 T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans Cancer Immunology Research. Jul, 2013 | Pubmed ID: 24432303 Identification of a Titin-derived HLA-A1-presented Peptide As a Cross-reactive Target for Engineered MAGE A3-directed T Cells Science Translational Medicine. Aug, 2013 | Pubmed ID: 23926201 A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: from Bench to Bedside Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2013 | Pubmed ID: 23838316 Cardiovascular Toxicity and Titin Cross-reactivity of Affinity-enhanced T Cells in Myeloma and Melanoma Blood. Aug, 2013 | Pubmed ID: 23770775 Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-intensity Conditioned Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jul, 2013 | Pubmed ID: 23635453 Innovation and Opportunity for Chimeric Antigen Receptor Targeted T cells Cytotherapy. Sep, 2013 | Pubmed ID: 23562306 Chimeric Antigen Receptor-modified T Cells for Acute Lymphoid Leukemia The New England Journal of Medicine. Apr, 2013 | Pubmed ID: 23527958 Autologous Lysate-pulsed Dendritic Cell Vaccination Followed by Adoptive Transfer of Vaccine-primed Ex Vivo Co-stimulated T Cells in Recurrent Ovarian Cancer Oncoimmunology. Jan, 2013 | Pubmed ID: 23482679 Phase 2 Clinical Trial of Rapamycin-resistant Donor CD4+ Th2/Th1 (T-Rapa) Cells After Low-intensity Allogeneic Hematopoietic Cell Transplantation Blood. Apr, 2013 | Pubmed ID: 23426943 Efficient Clinical Scale Gene Modification Via Zinc Finger Nuclease-targeted Disruption of the HIV Co-receptor CCR5 Human Gene Therapy. Mar, 2013 | Pubmed ID: 23360514 Antiviral Effects of Autologous CD4 T Cells Genetically Modified with a Conditionally Replicating Lentiviral Vector Expressing Long Antisense to HIV Blood. Feb, 2013 | Pubmed ID: 23264589 Convergence of Gene and Cell Therapy Regenerative Medicine. Nov, 2012 | Pubmed ID: 23210811 Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with Neuroblastoma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 12, 2012 | Pubmed ID: 23092876 Decade-long Safety and Function of Retroviral-modified Chimeric Antigen Receptor T Cells Science Translational Medicine. May, 2012 | Pubmed ID: 22553251 Costimulated Tumor-infiltrating Lymphocytes Are a Feasible and Safe Alternative Donor Cell Therapy for Relapse After Allogeneic Stem Cell Transplantation Blood. Mar, 2012 | Pubmed ID: 22289893 Phase I/II Randomized Trial of Dendritic Cell Vaccination with or Without Cyclophosphamide for Consolidation Therapy of Advanced Ovarian Cancer in First or Second Remission Cancer Immunology, Immunotherapy : CII. May, 2012 | Pubmed ID: 22021066 The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells Science Translational Medicine. Nov, 2011 | Pubmed ID: 22133721 Optimizing Parameters for Clinical-scale Production of High IL-12 Secreting Dendritic Cells Pulsed with Oxidized Whole Tumor Cell Lysate Journal of Translational Medicine. Nov, 2011 | Pubmed ID: 22082029 Phase I Trial of Adoptive Cell Transfer with Mixed-profile Type-I/type-II Allogeneic T Cells for Metastatic Breast Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2011 | Pubmed ID: 21948234 T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia Science Translational Medicine. Aug, 2011 | Pubmed ID: 21832238 Chimeric Antigen Receptor-modified T Cells in Chronic Lymphoid Leukemia The New England Journal of Medicine. Aug, 2011 | Pubmed ID: 21830940 Engineered Artificial Antigen Presenting Cells Facilitate Direct and Efficient Expansion of Tumor Infiltrating Lymphocytes Journal of Translational Medicine. Aug, 2011 | Pubmed ID: 21827675 Massive Ex Vivo Expansion of Human Natural Regulatory T Cells (T(regs)) with Minimal Loss of in Vivo Functional Activity Science Translational Medicine. May, 2011 | Pubmed ID: 21593401 Combination Immunotherapy Using Adoptive T-cell Transfer and Tumor Antigen Vaccination on the Basis of HTERT and Survivin After ASCT for Myeloma Blood. Jan, 2011 | Pubmed ID: 21030558 Infusion of Ex Vivo Expanded T Regulatory Cells in Adults Transplanted with Umbilical Cord Blood: Safety Profile and Detection Kinetics Blood. Jan, 2011 | Pubmed ID: 20952687 Transfer of Influenza Vaccine-primed Costimulated Autologous T Cells After Stem Cell Transplantation for Multiple Myeloma Leads to Reconstitution of Influenza Immunity: Results of a Randomized Clinical Trial Blood. Jan, 2011 | Pubmed ID: 20864577 Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor Cancer Research. Nov, 2010 | Pubmed ID: 20926399 Program Death-1 Signaling and Regulatory T Cells Collaborate to Resist the Function of Adoptively Transferred Cytotoxic T Lymphocytes in Advanced Acute Myeloid Leukemia Blood. Oct, 2010 | Pubmed ID: 20570856 Rapamycin Generates Anti-apoptotic Human Th1/Tc1 Cells Via Autophagy for Induction of Xenogeneic GVHD Autophagy. May, 2010 | Pubmed ID: 20404486 4-1BB and CD28 Signaling Plays a Synergistic Role in Redirecting Umbilical Cord Blood T Cells Against B-cell Malignancies Human Gene Therapy. Jan, 2010 | Pubmed ID: 19719389 Efficient Clinical-scale Enrichment of Lymphocytes for Use in Adoptive Immunotherapy Using a Modified Counterflow Centrifugal Elutriation Program Cytotherapy. 2009 | Pubmed ID: 19903104 Depletion of Endogenous Tumor-associated Regulatory T Cells Improves the Efficacy of Adoptive Cytotoxic T-cell Immunotherapy in Murine Acute Myeloid Leukemia Blood. Oct, 2009 | Pubmed ID: 19724059 Rapid Immune Recovery and Graft-versus-host Disease-like Engraftment Syndrome Following Adoptive Transfer of Costimulated Autologous T Cells Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2009 | Pubmed ID: 19509133 Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T Cells Molecular Therapy : the Journal of the American Society of Gene Therapy. May, 2009 | Pubmed ID: 19259065 Adoptive Immunotherapy: Good Habits Instilled at Youth Have Long-term Benefits Immunologic Research. 2008 | Pubmed ID: 18949448 CD28 Costimulation is Essential for Human T Regulatory Expansion and Function Journal of Immunology (Baltimore, Md. : 1950). Aug, 2008 | Pubmed ID: 18684977 A More Precise HIV Integration Assay Designed to Detect Small Differences Finds Lower Levels of Integrated DNA in HAART Treated Patients Virology. Sep, 2008 | Pubmed ID: 18649912 T Lymphocyte Engineering Ex Vivo for Cancer and Infectious Disease Expert Opinion on Biological Therapy. Apr, 2008 | Pubmed ID: 18352851 Identification and in Vitro Expansion of Functional Antigen-specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection Journal of Virology. May, 2008 | Pubmed ID: 18337568 Sleeping Beauty Transposon-mediated Engineering of Human Primary T Cells for Therapy of CD19+ Lymphoid Malignancies Molecular Therapy : the Journal of the American Society of Gene Therapy. Mar, 2008 | Pubmed ID: 18227839 Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating Stem Cell Differentiation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Oct, 2007 | Pubmed ID: 17889349 CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival Blood. Jun, 2007 | Pubmed ID: 17311991 Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion Cancer Research. Feb, 2007 | Pubmed ID: 17293384 Gene Transfer in Humans Using a Conditionally Replicating Lentiviral Vector Proceedings of the National Academy of Sciences of the United States of America. Nov, 2006 | Pubmed ID: 17090675 Stable Gene Transfer and Expression in Human Primary T Cells by the Sleeping Beauty Transposon System Blood. Jan, 2006 | Pubmed ID: 16189271 Adoptive Transfer of Costimulated T Cells Induces Lymphocytosis in Patients with Relapsed/refractory Non-Hodgkin Lymphoma Following CD34+-selected Hematopoietic Cell Transplantation Blood. Sep, 2003 | Pubmed ID: 12763934 TRANCE- and CD40 Ligand-matured Dendritic Cells Reveal MHC Class I-restricted T Cells Specific for Autologous Tumor in Late-stage Ovarian Cancer Patients Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2003 | Pubmed ID: 12684428 Adoptive Transfer of Costimulated CD4+ T Cells Induces Expansion of Peripheral T Cells and Decreased CCR5 Expression in HIV Infection Nature Medicine. Jan, 2002 | Pubmed ID: 11786906 İnsan CRISPR-Engineered CAR-T Hücrelerinin Üretimi Sangya Agarwal*1,2, Nils Wellhausen*1,2, Bruce L. Levine1,2, Carl H. June1,2 1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, 2Parker Institute for Cancer Immunotherapy, University of Pennsylvania JoVE 62299 Immunologia e infezioni
İnsan CRISPR-Engineered CAR-T Hücrelerinin Üretimi Sangya Agarwal*1,2, Nils Wellhausen*1,2, Bruce L. Levine1,2, Carl H. June1,2 1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, 2Parker Institute for Cancer Immunotherapy, University of Pennsylvania JoVE 62299 Immunologia e infezioni